FindTrial
Sign In

MANAGEMENT OF INFERTILITY W.S.R TO ANOVULATION

A comparative clinical study of virechana followed by lashuna taila uttarbasti and phalaghrita orally in bandhyatava (anovulatory factor of female infertility)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/07/026495
Enrollment
20
Registered
2020-07-10
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N970- Female infertility associated withanovulation

Interventions

Intervention1: Lashunadi taila intrauterine: 3 to 5ml for two consecutive cycles for 6 alternate sittings Control Intervention1: Phala ghrita orally: Patient will be treated by virechana karma followe

Sponsors

Gurukul Campus UAU Haridwar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: patient with primary or secondary infertility infertility due to PCOS, Due to decreased ovarian reserve Complaint of irregular menses Anovulatory cycle Oligo-ovulation

Exclusion criteria

Exclusion criteria: patient with vaginal and cervical infection, suffering from DUB, with cervical tumours,cervical stenosis, polyp, CA cervix,Tubal block, Congenital anamolies in female genital tract,HIV/VDRL/HbsAg positive

Design outcomes

Primary

MeasureTime frame
It will be asssesed after 2 months for ovulationTimepoint: ovulation/conceived-100%relief increased size of follicles-79-99%relief improvement in menstrual cycle -51-75%relief improvement in cervical mucous-26-50%relief unchanged-25% relief—

Secondary

MeasureTime frame
Increased follicular size and ovulationTimepoint: 2 months—

Countries

India

Contacts

Public ContactDr Pravesh Kumar

Gurukul Campus,Uttarakhand ayurveda University,Haridwar

Praveshk312@gmail.com9411775825

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026